7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,592.02

+550.63

+0.71%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

LSE - Delayed Quote GBp

Convatec Group PLC (CTEC.L)

244.40 +1.20 (+0.49%)

At close: October 30 at 4:47:03 PM GMT

Loading Chart for CTEC.L

Chart Range Bar

Interval:

In partnership with ChartIQ

Convatec Recognized With Two Prestigious Vizient® Supplier Excellence Awards

Convatec Recognized With Two Prestigious Vizient® Supplier Excellence Awards

Is Convatec Group (LSE:CTEC) Trading Below Fair Value On Cash Flow?

Is Convatec Group (LSE:CTEC) Trading Below Fair Value On Cash Flow?

Convatec Expands Cure™ Portfolio With Launch of Cure Aqua™, Bringing Greater Choice to People Who Catheterize

Convatec Expands Cure™ Portfolio With Launch of Cure Aqua™, Bringing Greater Choice to People Who Catheterize

ConvaTec Group H1 Earnings Call Highlights

ConvaTec Group H1 Earnings Call Highlights

How The Convatec Group (LSE:CTEC) Investment Narrative Is Evolving With An Unchanged Fair Value

How The Convatec Group (LSE:CTEC) Investment Narrative Is Evolving With An Unchanged Fair Value

Ostomy Dressing Market Forecasts Growth from $3.80B (2026) to $4.73B by 2031, Profiling Coloplast, ConvaTec, Hollister, B. Braun & Salts Healthcare

Ostomy Dressing Market Forecasts Growth from $3.80B (2026) to $4.73B by 2031, Profiling Coloplast, ConvaTec, Hollister, B. Braun & Salts Healthcare

ConvaTec Group Capital Markets Day: New “Accelerate” Plan Targets 6%-8% Growth, Mid-20s Margins

ConvaTec Group Capital Markets Day: New “Accelerate” Plan Targets 6%-8% Growth, Mid-20s Margins

ConvaTec Group H2 Earnings Call Highlights

ConvaTec Group H2 Earnings Call Highlights

UBS sees attractive risk/reward in three European medtech into Q3 results

UBS sees attractive risk/reward in three European medtech into Q3 results

Convatec Survey Challenges Assumptions About Leakage in Ostomy Care

Convatec Survey Challenges Assumptions About Leakage in Ostomy Care

Fevertree Drinks And 2 Other UK Stocks That Might Be Trading Below Their Estimated Value

Fevertree Drinks And 2 Other UK Stocks That Might Be Trading Below Their Estimated Value

Mobilize your Website

View Site in Mobile | Classic

Share by: